$42.29
Currently 35 wall-street analysts regularly analyze the financials of Crispr Therapeutics Ag on a frequent basis to provide recommendations along with target share price. 35 analysts offering 12-month price forecasts for Crispr Therapeutics Ag (CRSP) have a share price target of $83.6. This median of share price forecast represents a 97.68% upside from the latest price of $42.29 as on 06.03.25.
As per the chart shown above, analysts believe that the Crispr Therapeutics Ag (CRSP) share price will touch around $83.6 in next 12-months.
Below is a chart showing the percentage difference between Crispr Therapeutics Ag's share price and its median forecast price. As on 06.03.25, the difference is -37.91%
Based on 35 analysts tracking and researching Crispr Therapeutics Ag (CRSP) share have hold recommendation on an average.
3M Ago | 1M Ago | Current | |
Buy | 11 | 11 | 11 |
Outperform | 8 | 8 | 8 |
Hold | 12 | 13 | 13 |
Underperform | 0 | 0 | 0 |
Sell | 3 | 3 | 3 |